Outcomes of Patients With Heart Failure Hospitalized in an Internal Medicine Unit
NCT ID: NCT04845126
Last Updated: 2022-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2021-03-01
2021-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators showed that patients, mainly elderly women with comorbidities, often had suboptimal heart failure treatment without an identified cause. The investigators tried, whenever possible, to optimize treatment before hospital discharge.
Our objective is now to analyze the 4-year outcome of these patients, including re-hospitalization for heart failure or death.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
French Observatory of Acute Heart Failure
NCT01080937
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
NCT04878263
Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure
NCT03902028
Optimizing Treatments for Heart Failure During Hospitalization
NCT05910437
PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes
NCT06338878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Fesler, PUPH
Role: STUDY_DIRECTOR
UH MONTPELLIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL21_0188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.